Neutropenia after the third cycle of etanercept: could it be due to immunogenicity?
Department of Medicine Penn State MS Hershey Medical Center Hershey, PA nolsen@hmc.psu.edu.
Nancy J
NJ
Olsen
Nada
N
Elmagboul
D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects*; D009503:Neutropenia / Q000139:chemically induced*; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept